How DNA learned to fold: Mapping 1,025 species in 3D

Summary

When we picture DNA, we often think of a flat twisted ladder. But inside a cell, the genome is folded into complex three-dimensional shapes. The way this genetic instruction manual is folded dictates how a cell actually reads its genes. To understand how this microscopic origami evolved over billions of years, researchers mapped the 3D genome organization of 1,025 different species, spanning from simple bacteria to complex animals, plants, and fungi.

By analyzing vast amounts of structural data, the scientists discovered that our ancient, single-celled ancestors likely had completely random, unstructured genomes. Over time, two distinct architectural styles emerged. Most bacteria adopted a strategy called "global folding," which is a broad spatial organization of the entire genome. As evolution marched on, this global folding technique became the dominant architectural style in the plant kingdom.

Meanwhile, the animal kingdom took a different path. The researchers found that animals increasingly relied on a "checkerboard" pattern, where specific compartments of genetic material are spatially sorted and grouped together. While early traces of this checkerboard style can be seen in archaea (ancient single-celled microbes), the pattern grew highly complex throughout animal evolution.

Why it matters.

At its core, this massive evolutionary atlas reinforces a fundamental rule of biology: structure determines function. By understanding how the genetic code is physically organized across the entire tree of life, scientists have a powerful new lens for studying how genes are controlled. This foundational map will help researchers track how changes in DNA architecture drive evolutionary leaps or cause biological malfunctions.

It is important to note that this is early-stage, basic science. The findings represent a broad evolutionary map and currently lack direct applications for clinical diagnostics or medical treatments. However, foundational discoveries like this are exactly what the biotech industry needs to guide future innovations in structural biology and gene-editing therapies.

From the source

The story in numbers.

Species analyzed: 1,025
Main higher-order architectures analyzed: 2

Keep the context

Follow the evidence.

This AI-assisted summary is a starting point. Read the original reporting for its methods, scope, and limitations.

Swapping RNA for DNA gives CRISPR a powerful new target

The gene-editing tool known as CRISPR has revolutionized biology, traditionally relying on a molecule called guide RNA to direct molecular scissors to a specific piece of DNA. However, researchers have discovered a surprising twist. A specific type of molecular scissors known as a Cas12 nuclease can actually be driven by a different genetic navigator. Instead of using traditional guide RNA, this enzyme can utilize guide DNA. This simple substitution fundamentally changes how the tool behaves in a cell. When scientists swap the guide RNA for guide DNA, the Cas12 nuclease stops targeting DNA and instead switches its focus to targeting RNA. RNA is the genetic messenger that helps carry instructions from our genes to the rest of the cell. By just changing the steering mechanism, scientists can completely redirect the cutting machinery to a brand new molecular target. While this discovery significantly expands the overall versatility of the CRISPR toolkit, it is still very preliminary. The current reports are based on an early-stage perspective and lack the quantitative data, clinical validation, and sample size metrics needed to fully understand how well it works in complex organisms.

Nature Biotechnology1 min read

Blood Immune Cells May Drive Spinal Cord Damage in ALS

Amyotrophic lateral sclerosis (ALS) is a severe condition that causes a progressive loss of nerve cells in the brain and spinal cord. While scientists have spent decades studying why these neurons fail, recent research published in Nature Neuroscience points to an unexpected culprit. The study reveals that the immune system is not merely reacting to the disease, but actually acts as an active driver of ALS pathology. To uncover this, researchers used advanced techniques called single-cell and spatial transcriptomic profiling. These tools allow scientists to look at the genetic activity of individual cells and map their exact physical locations in the body. Using these methods, the team observed that immune cells from the bloodstream are infiltrating the central nervous system. Once there, these immune cells undergo a reprogramming process that directly links changes in the blood to the severe spinal cord damage seen in ALS patients.

Nature Neuroscience1 min read

A Domino Effect: How the Immune System Accelerates ALS

Amyotrophic lateral sclerosis, commonly known as ALS, is a devastating disease that gradually destroys the nerve cells responsible for movement. For years, scientists have puzzled over why the condition progresses rapidly in some patients while others survive much longer. Now, researchers at Northwestern University have uncovered a domino-like cascade that helps explain how the disease unfolds. Rather than a single catastrophic event, ALS appears to start with an internal breakdown inside motor neurons involving a toxic buildup of a protein called TDP-43. This initial damage then triggers a secondary, highly destructive response from the body's own immune system. By examining blood and spinal cord samples from hundreds of living and deceased patients, the scientists mapped out exactly where and how this immune reaction occurs. They discovered that inflamed immune cells from the bloodstream travel into the central nervous system, gathering directly at the sites where motor neurons are dying and toxic proteins are accumulating. Patients with the fastest disease progression had the most intense spinal cord inflammation and higher activity in complement genes, which produce proteins that act as the body's first line of immune defense against damage. Interestingly, the study also revealed that this immune response looks different depending on the root cause of the patient's condition. By analyzing the genetic instructions inside individual cells, the researchers found distinct immune patterns when comparing genetic and non-genetic forms of ALS. This suggests that the immune system reacts uniquely to different variations of the disease.

GEN2 min read

Follow your curiosity.

How DNA learned to fold: Mapping 1,025 species in 3D

Summary

Why it matters.

The story in numbers.

Follow the evidence.

Your next discovery.

Swapping RNA for DNA gives CRISPR a powerful new target

Blood Immune Cells May Drive Spinal Cord Damage in ALS

A Domino Effect: How the Immune System Accelerates ALS

Summary

Why it matters.

The story in numbers.

Follow the evidence.

Your next discovery.

Swapping RNA for DNA gives CRISPR a powerful new target

Blood Immune Cells May Drive Spinal Cord Damage in ALS

A Domino Effect: How the Immune System Accelerates ALS

A little science goes a long way.